Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Financial statements
Income statement Balance sheet Cash flow
Annual Quarterly
Revenue4 5 $0 in 20190 2017: $0 $0 2017 2018: $0 $0 2018 2019: $0 $0 2019 Operating income4 5 6 -$258.5K in 2019+426% since 2017 -$300.0K -$200.0K -$100.0K 0 2017: -$49.1K -$49.1K 2017 2018: -$122.6K -$122.6K 2018 +149% 2019: -$258.5K -$258.5K 2019 +111% Net income7 5 8 -$258.7K in 2019+283% since 2017 -$300.0K -$200.0K -$100.0K 0 2017: -$67.6K -$67.6K 2017 2018: -$113.1K -$113.1K 2018 +67% 2019: -$258.7K -$258.7K 2019 +129% Revenue9 10 $0 in Q2 FY20240 Q1 FY2024: $0 $0 Q1 FY2024 Q2 FY2024: $0 $0 Q2 FY2024 Operating income9 10 -$477.2K in Q2 FY2024−30% since Q1 FY2024 -$800.0K -$600.0K -$400.0K -$200.0K 0 Q1 FY2024: -$682.8K -$682.8K Q1 FY2024 Q2 FY2024: -$477.2K -$477.2K Q2 FY2024 −30% Net income9 10 -$799.2K in Q2 FY2024+22% since Q1 FY2024 -$800.0K -$600.0K -$400.0K -$200.0K 0 Q1 FY2024: -$654.7K -$654.7K Q1 FY2024 Q2 FY2024: -$799.2K -$799.2K Q2 FY2024 +22% Fiscal year 2017 2018 2019 Revenue $04 $05 $05 Research and development Operating income -$49.1K4 -$122.6K5 -$258.5K6 Interest $18.5K4 $10.5K5 $2496 Income tax $23.0K4 $17.9K11 $82.5K6 Net income -$67.6K7 -$113.1K5 -$258.7K8
Total assets5 6 $14.7K in 2019−71% since 2018 0 $20.0K $40.0K $60.0K 2018: $50.7K $50.7K 2018 2019: $14.7K $14.7K 2019 −71% Total liabilities4 5 6 $217.5K in 2019−26% since 2017 0 $100.0K $200.0K $300.0K 2017: $294.7K $294.7K 2017 2018: $106.3K $106.3K 2018 −64% 2019: $217.5K $217.5K 2019 +105% Shareholders’ equity5 6 -$202.7K in 2019−31% since 2017 -$300.0K -$200.0K -$100.0K 0 2017: -$294.7K -$294.7K 2017 2018: -$55.6K -$55.6K 2018 −81% 2019: -$202.7K -$202.7K 2019 +265% Cash5 6 $0 in 20190 2017: $0 $0 2017 2018: $0 $0 2018 2019: $0 $0 2019 Long-term debt4 5 $0 in 20190 $5.0K $10.0K $15.0K $20.0K 2017: $0 $0 2017 2018: $19.9K $19.9K 2018 2019: $0 $0 2019 Total assets9 10 $1.4M in Q2 FY2024+37139% since Q1 FY2024 0 $500.0K $1.0M $1.5M Q1 FY2024: $3.7K $3.7K Q1 FY2024 Q2 FY2024: $3.7K $3.7K Q2 FY2024 +0% Q1 FY2024: $975.2K $975.2K Q1 FY2024 +26524% Q2 FY2024: $1.4M $1.4M Q2 FY2024 +40% Total liabilities9 10 $3.6M in Q2 FY2024+171% since Q1 FY2024 0 $1.0M $2.0M $3.0M $4.0M Q1 FY2024: $1.3M $1.3M Q1 FY2024 Q2 FY2024: $1.3M $1.3M Q2 FY2024 +0% Q1 FY2024: $2.4M $2.4M Q1 FY2024 +83% Q2 FY2024: $3.6M $3.6M Q2 FY2024 +48% Shareholders’ equity9 10 -$2.1M in Q2 FY2024+55% since Q1 FY2024 -$3.0M -$2.0M -$1.0M 0 Q1 FY2024: -$1.3M -$1.3M Q1 FY2024 Q2 FY2024: -$1.3M -$1.3M Q2 FY2024 +0% Q1 FY2024: -$1.4M -$1.4M Q1 FY2024 +3% Q2 FY2024: -$2.1M -$2.1M Q2 FY2024 +49% Cash9 10 $82.7K in Q2 FY2024+3017% since Q1 FY2024 0 $200.0K $400.0K $600.0K $800.0K Q1 FY2024: $2.7K $2.7K Q1 FY2024 Q2 FY2024: $2.7K $2.7K Q2 FY2024 +0% Q1 FY2024: $714.3K $714.3K Q1 FY2024 +26813% Q2 FY2024: $82.7K $82.7K Q2 FY2024 −88% Fiscal year 2017 2018 2019 Cash $05 $06 $06 Current assets $50.7K4 $14.7K6 Total assets $50.7K5 $14.7K6 Current liabilities $294.7K4 $86.4K5 $217.5K6 Long-term debt $04 $19.9K5 $05 Total liabilities $294.7K4 $106.3K5 $217.5K6 Shareholders’ equity -$294.7K5 -$55.6K6 -$202.7K6 Shares outstanding 115.0M shares12
Cash from operations4 5 6 $0 in 2019-$20.0K -$15.0K -$10.0K -$5.0K 0 2017: $0 $0 2017 2018: -$19.9K -$19.9K 2018 2019: $0 $0 2019 −100% Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Fiscal year 2017 2018 2019 Cash from operations $04 -$19.9K5 $06
Compare ALTEROLA BIOTECH INC. with another company
Former names
JEDEDIAH RESOURCES CORP. Dec 12, 2008 to Nov 19, 20103
Recent filings
Jun 30, 2025 8-K Nov 29, 2024 10-Q Nov 25, 2024 10-Q/A Sep 30, 2024 8-K Sep 12, 2024 8-K Aug 15, 2024 10-Q Jul 18, 2024 10-K Feb 21, 2024 10-Q/A Feb 20, 2024 10-Q Nov 21, 2023 10-Q Oct 20, 2023 8-K Oct 17, 2023 8-K Sep 19, 2023 8-K Aug 15, 2023 10-Q Jul 10, 2023 10-K Every filing from the last three years, summarized . The full record is on SEC EDGAR.1
